Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-26-044291

President and CEO sold 21,000 shares at $13.72 ($288,120)

  • President and CEO acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Grossman Adam S · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Exercise or conversion : show line 1 in the form 10b5-1 +15,000 $5.40 $81,000 2,085,777 D
2026-11-16 Sale : show line 2 in the form 10b5-1 −15,000 $13.72 $205,800 2,070,777 D
2026-11-16 Sale : show line 3 in the form 10b5-1 −6,000 $13.72 $82,320 2,064,777 D
Open-market sales · 21,000 sh · avg $13.72 · $288,120

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-16 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −15,000 570,950 D
Loading xslF345X06/form4.xml…